Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 9,950.00
-180.00 (-1.78%)
Feb 26, 2026, 2:28 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 56.02 billion as of February 25, 2026. Its market cap has decreased by -24.85% in one year.
Market Cap
56.02B
Enterprise Value
32.27B
Revenue
24.56B
Ranking
n/a
PE Ratio
16.33
Stock Price
9,950.00
Market Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 56.02B, a decrease of -80.52%. That is a compound annual growth rate of -66.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 56.02B | 2.84% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.99T |
| Celltrion | 53.52T |
| ALTEOGEN | 21.50T |
| Sam Chun Dang Pharm. | 13.56T |
| MYUNGMOON Pharm co.,Ltd | 63.95B |
| METACARE CO. | 59.95B |
| HASS Corp. | 59.76B |
| IVIM Technology | 55.11B |